Todays 2006 Q4 Conference Call transcript is now available

The Q&A portion is a must read, here is a snippet:

Has Malik – Citigroup:

Thanks very much. Can I ask a
question on the timing of the ramp of new products? And specifically,
if you look at the N95, the 6300, and the Barracuda, respectively when
would you hope to be it kind of a full quarterly commercial run rate in
volume terms for each of those products?

Olli-Pekka Kallasvuo:

Okay,
Olli-Pekka here. So, when it comes to the 6300, so we started selling
that or shipping that product on Monday of last week, and we are
ramping up. And in fact, if I look at the ramp up, it’s proceeding
well, and also the demand for that product in the marketplace is very,
very good. I think it really will be a hit. Now N95, we have said that
we will — but of course, having said that, we always have to remember
that a product is not ramp up to the full volumes in two or three
weeks. It takes a bit longer time. Of course we are talking about sort
of big numbers here. So in that way, it takes a while, but the ramp up
as such is going well. Now, when it comes to N95, we have said that we
have introduced — we will launch or start shipping in the first
quarter and that continues to be the plan. It’s a very complex product
and the ramp up there is a bit slower than with the products like 6300
which is easier to ramp up. And then the Barracuda, so to speak, that
you don’t even know the number yet. So, it will happen when that is
ready.

Source: Seeking Alpha

It’s a one hour conversation presented in text, took me less than 15 minutes to read. Definitely packed with content so don’t rush yourself.